Helius Medical Technologies, Inc. provided earnings guidance for the Second Quarter of 2022. For the period, the Company currently expects second quarter revenue to be modestly above the first quarter levels, factoring in potential delays for some portion of U.S. patients to pursue insurance coverage prior to filling their prescriptions.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | -4.12% | -43.21% | -79.72% |
May. 07 | Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Traders Assess Earnings | MT |
May. 07 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.72% | 4.38M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Earnings Guidance for the Second Quarter of 2022